Avocado Fruit on Postprandial Markers of the Glycemic Response, Satiety/Appetite and Cardiometabolic Risk
AVOC1
The Impact of Avocado Fruit on Postprandial Markers of the Glycemic Response, Satiety/Appetite and Cardiometabolic Risk: An Acute Dose Response Study
1 other identifier
interventional
29
1 country
1
Brief Summary
The primary goal is to characterize the acute effects of avocado intake on glycemic and satiety/ appetite responses in relatively healthy overweight / obese adults. The secondary goal is to investigate risk factors for cardio-metabolic disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 19, 2015
CompletedFirst Posted
Study publicly available on registry
June 23, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedJuly 14, 2020
July 1, 2020
4.3 years
June 19, 2015
July 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in postprandial blood glucose concentration response for treatments compared to control over 6-hour postprandial period
postprandial blood glucose concentration response
Baseline to 6 hours
Secondary Outcomes (4)
Changes in postprandial endothelial function using Flow Mediated Dilation (FMD) for treatments compared to control
Baseline to 6 hours
Change in postprandial blood insulin and triglycerides concentration response for treatments compared to control over 6-hour postprandial period
Baseline to 6 hours
Changes in postprandial subjective satiety responses using visual analog scales (VAS) for treatments compared to control over 6-hour postprandial period
Baseline to 6 hours
Changes in postprandial gut hormones related to satiety for treatments compared to control over 6-hour postprandial period
Baseline to 6 hours
Other Outcomes (3)
Changes in postprandial lipoproteins responses for treatments compared to control
Baseline to 6 hours
Changes in postprandial inflammation responses for treatments compared to control
Baseline to 6 hours
Changes in postprandial oxidation responses for treatments compared to control
Baseline to 6 hours
Study Arms (3)
Test meal 1 (TM1)
ACTIVE COMPARATORHigh fat meal (HF) with ½ avocado (\~68g)
Test meal 2 (TM2)
ACTIVE COMPARATORHigh fat meal (HF) with 1 avocado (\~136g)
Control meal (CM)
PLACEBO COMPARATORHigh carbohydrate, high saturated fat control meal (CM) without avocado.
Interventions
High fat meal (HF) with ½ avocado (\~68g), matched to CM for energy content; not matched for macronutrient content or type (e.g., fat type).
High fat meal (HF) with 1 avocado (\~136g) matched for energy but not macronutrient content or type.
High carbohydrate, high saturated fat control meal (CM) without avocado.
Eligibility Criteria
You may qualify if:
- Men and women aged 25-60 yrs.
- BMI of 25 - 35 kg/m2
- No clinical evidence / history of cardiovascular, respiratory, renal, gastrointestinal, or hepatic disease
- Not taking over-the-counter or prescription medications / dietary supplements that may interfere with study procedures or endpoints (e.g., antioxidant supplements, anti-inflammatory, lipid-lowering or blood pressure lowering medications.
- Fasting blood glucose of 90-115 mg/dl
- Fasting insulin \< 13 U/L
- Non-smoker or past smoker (smoking cessation \> 2 yrs.)
- has at least 1 large, sturdy and well anchored vein in order to place a catheter
You may not qualify if:
- Aged \< 25 or \> 60 years
- BMI \< 25 kg/m2 or \> 35 kg/m2
- History of cardiovascular, respiratory, renal, gastrointestinal or hepatic disease
- Diabetes
- Uncontrolled blood pressure (\>140 / 90 mmHg)
- Have or had cancer other than non-melanoma skin cancer in past 5 years
- Taking over-the-counter or prescription medications or dietary supplements that may interfere with study procedures or endpoints (including protein powers, energy drinks)
- Fasting blood glucose \<90 or \> 115 mg/dl
- Fasting insulin ≥ 13 U/L
- Vegan dietary habits, unusual dietary habits or sensitive or allergic to any of the test meal components / ingredients
- Dislike avocados or non-consumers of avocados
- Current smoker
- Actively losing weight or trying to lose weight
- Drug or alcohol addiction
- Present with significant psychiatric or neurological disturbances
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Nutrition Research Center
Chicago, Illinois, 60616, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Britt Burton-Freeman, Ph.D
Illinois Institute of Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 19, 2015
First Posted
June 23, 2015
Study Start
June 1, 2015
Primary Completion
October 1, 2019
Study Completion
October 1, 2019
Last Updated
July 14, 2020
Record last verified: 2020-07